Leishmaniasis worldwide and global estimates of its incidence J Alvar, ID Vélez, C Bern, M Herrero, P Desjeux, J Cano, J Jannin, M Boer, ... PloS one 7 (5), e35671, 2012 | 6084 | 2012 |
The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000 M Kosek, C Bern, RL Guerrant Bulletin of the world health organization 81, 197-204, 2003 | 2475 | 2003 |
Report of the committee on Infectious disease American Academy of Pediatrics Red Book 2006, 401-410, 2006 | 1739* | 2006 |
The magnitude of the global problem of diarrhoeal disease: a ten-year update. C Bern, J Martines, I De Zoysa, RI Glass Bulletin of the world health organization 70 (6), 705, 1992 | 1334 | 1992 |
Leishmaniasis and poverty J Alvar, S Yactayo, C Bern Trends in parasitology 22 (12), 552-557, 2006 | 1088 | 2006 |
Chagas’ disease C Bern New England Journal of Medicine 373 (5), 456-466, 2015 | 1048 | 2015 |
Evaluation and treatment of Chagas disease in the United States: a systematic review C Bern, SP Montgomery, BL Herwaldt, A Rassi, JA Marin-Neto, ... Jama 298 (18), 2171-2181, 2007 | 981 | 2007 |
Trypanosoma cruzi and Chagas' disease in the United States C Bern, S Kjos, MJ Yabsley, SP Montgomery Clinical microbiology reviews 24 (4), 655-681, 2011 | 860 | 2011 |
Chagas disease in Spain, the United States and other non-endemic countries J Gascon, C Bern, MJ Pinazo Acta tropica 115 (1-2), 22-27, 2010 | 821 | 2010 |
Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis IM Sulaiman, R Fayer, C Bern, RH Gilman, JM Trout, PM Schantz, P Das, ... Emerging infectious diseases 9 (11), 1444, 2003 | 780 | 2003 |
An estimate of the burden of Chagas disease in the United States C Bern, SP Montgomery Clinical Infectious Diseases 49 (5), e52-e54, 2009 | 734 | 2009 |
Identification of 5 Types of Cryptosporidium Parasites in Children in Lima, Peru L Xiao, C Bern, J Limor, I Sulaiman, J Roberts, W Checkley, L Cabrera, ... The Journal of infectious diseases 183 (3), 492-497, 2001 | 706 | 2001 |
Complexities of assessing the disease burden attributable to leishmaniasis C Bern, JH Maguire, J Alvar PLoS neglected tropical diseases 2 (10), e313, 2008 | 504 | 2008 |
Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association MCP Nunes, A Beaton, H Acquatella, C Bern, AF Bolger, LE Echeverría, ... Circulation 138 (12), e169-e209, 2018 | 438 | 2018 |
Liposomal amphotericin B for the treatment of visceral leishmaniasis LD Saravolatz, C Bern, J Adler-Moore, J Berenguer, M Boelaert, ... Clinical Infectious Diseases 43 (7), 917-924, 2006 | 393 | 2006 |
Cryptosporidium species and subtypes and clinical manifestations in children, Peru VA Cama, C Bern, J Roberts, L Cabrera, CR Sterling, Y Ortega, ... Emerging infectious diseases 14 (10), 1567, 2008 | 385 | 2008 |
Antitrypanosomal therapy for chronic Chagas' disease C Bern New England Journal of Medicine 364 (26), 2527-2534, 2011 | 374 | 2011 |
Differences in Clinical Manifestations among Cryptosporidium Species and Subtypes in HIV-Infected Persons VA Cama, JM Ross, S Crawford, V Kawai, R Chavez-Valdez, D Vargas, ... The Journal of infectious diseases 196 (5), 684-691, 2007 | 330 | 2007 |
Magnitude of the disease burden from neurocysticercosis in a developing country C Bern, HH Garcia, C Evans, AE Gonzalez, M Verastegui, VCW Tsang, ... Clinical Infectious Diseases 29 (5), 1203-1209, 1999 | 305 | 1999 |
Test performance evaluation of SARS-CoV-2 serological assays JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Nature biotechnology 38 (10), 1174, 2020 | 265 | 2020 |